top of page

Our Team

Lior Carmon


Founder, Owner

Dr Lior Carmon, is a biotech entrepreneur with a strong scientific background and in-depth experience in translational medicine. Lior has specialized in immunology mainly immune-oncology, vaccinology and has a proven record of founding, funding and managing life sciences ventures, all the way from a mere idea and into advanced human clinical trials. He has been a pioneer and opinion leader in using signal peptide domains (SPD) to develop superior vaccines. In the last 24 years, Dr Carmon has served as an entrepreneur and executive in key Israeli biotech companies. He is a founder, CEO, and head of R&D at VaxilBio Ltd. which developed SPD-based cancer and tuberculosis vaccines and novel SPD antibodies. He is also a co-founder and VP for business development at two companies in the field of immunology Biokine and CureTech. Dr Carmon has a Ph.D. in immunology (Weizmann Institute), and MBA (Ben-Gurion University), with 25 published scientific articles and patents.


Riva Kovjazin

MD, Head of

immune R&D

Dr Riva Kovjazin, is an expert in the field of innate and adaptive Immunology with >40 years of experience in designing and performing basic and clinical immunology. She specializes in advanced study of immunology and epidemiology of conventional infectious diseases. She also spent a few years as a team leader at the Centre for clinical immunology, University of Medicine, Moscow, Russia where she studies Clinical immunology and diagnosis aspects of HIV. From 1997-2007, Dr Kovjazin held various positions at XTL in Cell Biology and Immunology. From 2007-2018, Dr Kovjazin worked at VaxilBio with Dr Carmon and together they established and implemented development methods for novel SPD as cancer vaccine and antibodies in cancer and anti-infective indications.


Nadav Carmon

Head of research & analysis

Nadav brings a diverse background to his role as Head of Research & Data Analyst at BIM. He studied biology as part of his high school education at Hakfar Hayarok and furthered his technical expertise by working for 4 years in the IDF's Technological Mamram unit as a Network and Security Engineer, developing systems and infrastructure crucial for cyber defense. Currently pursuing a degree in Neuroscience, Nadav combines his vast knowledge and experience in computer and biology to drive AI –linked innovation in biopharma.

Nadav is responsible for researching new technologies, collaborating with external companies, and integrating AI into the workforce. His strategic insights and proficiency in data analysis empower his team to make informed decisions.

NOA NEW5.jpg

Noa Carmon

Head of design

& digital marketing

Noa, the head of Design & Digital Marketing at BIM, expertly blends artistic flair with strategic digital acumen. Her journey began at Israel’s renowned Thelma Yellin Art High School, continuing at Shenkar Design College, where she explored foreign studies and textile design, marrying traditional artistry with modern design. Specializing in design, branding, and art, Noa has been pivotal in sculpting BIM's visual and digital presence. A significant part of her role involves leading successful LinkedIn campaigns, showcasing her adeptness in leveraging digital platforms to enhance brand visibility and market penetration. Noa's work, characterized by a unique blend of creativity and strategic market insight, not only pushes the envelope but also firmly establishes BIM's brand at the pinnacle of its industry.

bottom of page